person

Juliette M.

Country
France
Department
Dermatology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 30 partner sites.

Specializations

Dermatology and Immune‑Mediated Skin Disorders

Investigator Juliette Miquel concentrates on chronic inflammatory skin diseases, emphasizing therapeutic strategies that modulate immune pathways.

  • atopic dermatitis
  • moderate to severe plaque psoriasis
  • vitiligo
  • skin repigmentation therapies

Research includes evaluation of biologics, JAK inhibitors, and phototherapy combinations.

Solid Tumor Oncology

Her work extends to a broad spectrum of solid cancers, targeting novel systemic and localized treatments.

  • non‑small cell lung cancer
  • cervical cancer
  • renal cell carcinoma
  • breast cancer in young women
  • head and neck squamous cell carcinoma

Efforts focus on immunotherapy‑chemotherapy combos and precision radiotherapy approaches.

Hematologic Malignancies

Juliette Miquel engages in clinical studies of blood‑derived cancers, exploring intensified chemotherapy and targeted agents.

  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • peripheral T‑cell lymphoma
  • multiple myeloma
  • high‑risk large B‑cell lymphoma

Key interests include graft‑versus‑host disease prophylaxis and novel antibody‑drug conjugates.

Infectious Diseases and Emerging Pathogens

She contributes to trials addressing bacterial, viral, and parasitic infections with unmet therapeutic needs.

  • nontuberculous mycobacterial lung infection
  • chikungunya virus disease
  • monkeypox virus disease
  • HIV‑HBV co‑infection
  • early syphilis

Investigations emphasize antiviral agents, inhaled antibiotic formulations, and vaccine efficacy.

Pediatric Neuro‑Oncology

Her portfolio includes rare central nervous system tumors in children and adolescents, aiming to improve survival while reducing treatment toxicity.

  • diffuse intrinsic pontine glioma
  • medulloblastoma
  • ependymoma
  • high‑risk neuroblastoma
  • rhabdomyosarcoma

Approaches integrate targeted molecular agents, radiation dose modulation, and immunotherapeutic regimens.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.